Q: Thoughts on PDEX?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Good morning. I am reading a JP Morgan report on Apple and they have EPS estimates for 2021 at $4.50. Which is 36% expected growth from their 2020 projection of 3.29. Do you have projections further out to 2022 or 2023? Thanks
Q: Good Day Folks,
What do you know about EHTH? It was highly recommended recently on CNBC and as far as I can tell from my on line search, it looks pretty attractive. Would it be a good time to take a position here?
Dennis
What do you know about EHTH? It was highly recommended recently on CNBC and as far as I can tell from my on line search, it looks pretty attractive. Would it be a good time to take a position here?
Dennis
Q: Are you still positive on crwd. outlook?
Q: Both NAVI and COOP look oddly undervalued even after one factors in known problems in their business models. NAVI pays a good dividend (too good?). COOP pays none. Is NAVI’s dividend well covered? COOP appears to trade at below book or is that incorrect? What do you calculate are the PEG ratios for each of theses companies? Financial sites give differing ratios.
What do you see as vulnerabilities that are perhaps not discernible to a non-finance professional? Interest rates are likely to remain low for several years; it appears the US economy will continue to be bolstered by at least some stimulus, however modest, through to at least end of year 2021. Would either company be a probable target by a new US Admin? I would be thankful for your looking under the hood. I am concerned there might be dangers of the type that are sometimes skipped even by premium finance sites.
Would you buy either company, and if yes, your preference (if any?)
What do you see as vulnerabilities that are perhaps not discernible to a non-finance professional? Interest rates are likely to remain low for several years; it appears the US economy will continue to be bolstered by at least some stimulus, however modest, through to at least end of year 2021. Would either company be a probable target by a new US Admin? I would be thankful for your looking under the hood. I am concerned there might be dangers of the type that are sometimes skipped even by premium finance sites.
Would you buy either company, and if yes, your preference (if any?)
Q: Thoughts on the quarter please. Is their 5% profit margin sustainable in the future?
thank you
thank you
Q: Hello. Would you be more optimistic about CTS after their 2Q results? Also being named as a top fast growth company? I am considering adding to my position. Thank you.
Q: Good morning 5i folks. Apparently, I've fallen behind on my financial acronym homework . I guess I need to bone up.
Can you enlighten me as to what constitutes a SPAC ?
Thanks, David
Can you enlighten me as to what constitutes a SPAC ?
Thanks, David
Q: With the pending vaccine and inoculations to come, just wondering if you may have a lead on a syringe manufacturer? It may be a good investment direction to consider. Thanks
Dennis
Dennis
Q: Hi Team
BNTX seems to be tanking with lots of positive news for vaccines.
Do you still consider this a good hold until at least year end ?
I hold in registered accounts so cap loss / gain is not an issue.
Thanks, Peter
BNTX seems to be tanking with lots of positive news for vaccines.
Do you still consider this a good hold until at least year end ?
I hold in registered accounts so cap loss / gain is not an issue.
Thanks, Peter
- BRP Inc. Subordinate Voting Shares (DOO)
- Vail Resorts Inc. (MTN)
- Polaris Inc. (PII)
- Columbia Sportswear Company (COLM)
Q: what is your take on stocks that look good for recovery plays in the US?.....asking this because I read your take on those in Canada.
Q: Can you comment on reasons for recent weakness. Would you hold on or take a loss ? I’m patient and willing to wait 12-18 months if you feel this is worthwhile.
Q: What do you think of Nuvei IPO?
Q: Hi guys : could you give me your opinion on the above stocks Thanks Gary
Q: What do you think if this company. If memory serves me well you had mentioned it as potential high flyer, notwithstanding it’s high risk profile.
Would you add new funds to it today?
Thanks
Would you add new funds to it today?
Thanks
Q: ABBV is being subpoena by congress about drug pricing and not cooperating as asked.
Down 4% this morning.Is this going to be a damper on the stock for a while? Thinking about selling when i am still even on stock.
tnx u..........
Down 4% this morning.Is this going to be a damper on the stock for a while? Thinking about selling when i am still even on stock.
tnx u..........
Q: I have both GOOG and GOOGL . I used to see the voting stock GOOGL trade above the non-voting GOOG. Lately however prices have reversed . This morning for example the voting shares are some $7 BELOW the non-voting class. This strikes one as odd, notwithstanding that votes have little meaning in companies where founders have controlling blocks. Has something changed in the definitions of the Classes? I did not see anything in the financial journals.
Q: Peter, Ryan and gang: a couple of weeks ago AYX took a dive and currently is trying slowly to regain its former price levels. What are your thoughts, hang in there or move on?
If your advice is move on, could you suggest two or three US stocks, maybe “cloud “ or “i t “ . I have a good risk tolerance and await your reply
John
If your advice is move on, could you suggest two or three US stocks, maybe “cloud “ or “i t “ . I have a good risk tolerance and await your reply
John
Q: I am puzzled by your July 16, 2020 comments in response to a question on JPM vs. MS. You wrote “.... we would not consider them very different overall. JPM is significantly larger” ; “ business mix is very similar”. JPM and MS look different to me. MS has no retail business . MS has or will have an even larger presence in wealth management after its announced acquisition of eTrade. The deal was announced early 2020. The transaction has been approved and is expected to close before end of year 2020. Further, the above is an all-stock deal and although that affects capital structure, it should have little impact on MS’ debt level. However I may have missed things in which case your clarification would be welcome.
If I am correct: is MS a holding that is well worth adding to? I have a full allocation to US financials but hold only a modest position in MS. I am thinking of reducing BAC, OR another US banks and add to MS. My reasoning primarily: MS is not much exposed to loan losses; the brokerage and wealth management businesses seem poised for much growth in the US; its business model looks more attractive for the next two to 3 years. Would you agree or am I missing some important factors?
If I am correct: is MS a holding that is well worth adding to? I have a full allocation to US financials but hold only a modest position in MS. I am thinking of reducing BAC, OR another US banks and add to MS. My reasoning primarily: MS is not much exposed to loan losses; the brokerage and wealth management businesses seem poised for much growth in the US; its business model looks more attractive for the next two to 3 years. Would you agree or am I missing some important factors?
Q: Hi,
To enhance growth potential in the low-interest and slow-growth environment, I am thinking of selling JPM to buy either V, MA or PYPL. Any suggestion and comment? I already own half position of V in my other account.
Thanks,
Martin
To enhance growth potential in the low-interest and slow-growth environment, I am thinking of selling JPM to buy either V, MA or PYPL. Any suggestion and comment? I already own half position of V in my other account.
Thanks,
Martin